Full Text View
Tabular View
No Study Results Posted
Related Studies
Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer
This study has been terminated.
Study NCT00437359   Information provided by Japan Breast Cancer Research Network

First Received on February 18, 2007.   Last Updated on March 28, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Neoplasms
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
Toremifene citrate
Anastrozole
Additional drug interventions recognized in this trial
Adjuvants, Immunologic
Aromatase Inhibitors
Citric Acid
Estrogen Antagonists
Estrogen Receptor Modulators
Toremifene
More general drug interventions related to this trial
Anticoagulants
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Chelating Agents
Enzyme Inhibitors
Hematologic Agents
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Selective Estrogen Receptor Modulators
Therapeutic Uses
Sponsors listed in this trial
Japan Breast Cancer Research Network


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services